MedTrace Logo

A Study Of Early Markers Of Choroidal Neovascularization

NCT00902785 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2010-11-10

No results posted yet for this study

Summary

Identify early markers of choroidal neovascularization (CNV) in the fellow eye of a patient with CNV in the other eye due to age-related macular degeneration with the expectation of being able to identify patients in need of intervention.

Conditions

  • Choroidal Neovascularization (CNV)
  • Age-related Macular Degeneration (AMD)
  • Early Markers

Interventions

OTHER

no drug

observational no drug

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2010-05-31
Completion
2010-05-31

Countries

  • Italy
  • Portugal
  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00902785 on ClinicalTrials.gov